Source link : https://newshealth.biz/health-news/investigational-glp-1-based-drug-hits-mash-resolution-mark-misses-fibrosis-target/
(MedPage Today) — WASHINGTON — Treatment with the investigational GLP-1/glucagon dual receptor agonist pemvidutide led to resolution of metabolic dysfunction-associated steatohepatitis (MASH) without worsening of fibrosis, but did not improve… Source link : https://www.medpagetoday.com/meetingcoverage/aasld/118438 Author : Publish date : 2025-11-11 15:03:00 Copyright for syndicated content belongs to the linked Source.
The post Investigational GLP-1-Based Drug Hits MASH Resolution Mark, Misses Fibrosis Target first appeared on News Health.
—-
Author : News Health
Publish date : 2025-11-11 15:03:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8